Tearlab (NASDAQ:TEAR) will report earnings after markets close on Tuesday, August 13th. TearLab Corp. is an in-vitro diagnostics company. The Company develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to test for sensitive and specific biomarkers in tears at the point-of-care.
Here is your Cheat Sheet to Tearlab Earnings:
Earnings Expectations: Analysts expect earnings of $-0.12 per share on revenues of $3.48 million.
Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a loss of $0.1 and has not changed. For the current year, the average estimate is a loss of $0.42, which is better than the estimate ninety days ago.
Here’s how Tearlab has been performing on an annual basis:
|Revenue ($) in millions||0||1||2||2||4|
|Diluted EPS ($)||-3.47||-0.44||-0.47||-0.50||0.00|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012||Mar. 31, 2013|
|Revenue ($) in millions||0.72||1.21||1.61||2.47|
|Diluted EPS ($)||-0.10||-0.17||-0.13||-0.30|
Tearlab has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)